Differential hemodynamic effects of oral enoximone in severe congestive heart failure
- 1 February 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 65 (7) , 515-519
- https://doi.org/10.1016/0002-9149(90)90822-i
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A Comparison of Oral Milrinone, Digoxin, and Their Combination in the Treatment of Patients with Chronic Heart FailureNew England Journal of Medicine, 1989
- New Positive Inotropic Agents in the Treatment of Congestive Heart FailureNew England Journal of Medicine, 1986
- New Positive Inotropic Agents in the Treatment of Congestive Heart FailureNew England Journal of Medicine, 1986
- Sudden unexpected death in patients with congestive heart failure: a second frontier.Circulation, 1985
- MDL 17,043 therapy in severe congestive heart failure: Characterization of the early and late hemodynamic, pharmacokinetic, hormonal and clinical responseJournal of the American College of Cardiology, 1985
- Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial.Circulation, 1985
- Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failureThe American Journal of Cardiology, 1984
- The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.Circulation, 1983
- Strategies for determination of serum or plasma norepinephrine by reverse-phase liquid chromatographyAnalytical Chemistry, 1981
- Application of a Radioimmunoassay for Angiotensin I to the Physiologic Measurements of Plasma Renin Activity in Normal Human Subjects1Journal of Clinical Endocrinology & Metabolism, 1969